PMI's IQOS Takes Over Italy with 2 Million Smokers

Feb.20.2023
PMI's IQOS Takes Over Italy with 2 Million Smokers
PMI president Marco Hannappel says 2 million Italian smokers have switched to IQOS, a high-tech alternative to smoking.

Recently, Marco Hannappel, President of Phillip Morris International (PMI) in Southwest Europe, stated that approximately two million smokers in Italy have switched to using IQOS.


We are rapidly advancing towards the goal of a 'smoke-free future' by providing adult smokers with higher technological alternatives," said Marco Hannappel.


The 2022 PMI annual report reveals that the shipment volume of heated tobacco products (HTP) in Italy reached 1.23 million units, representing a 37.7% YoY growth. Italy has become PMI's largest market for HTP in Europe, second only to Russia.


According to Gianluca Iannelli, the marketing and digital director of PMI Italy, the company has recently launched a new product called IQOS Iluma One in the Italian market. PMI aims to use this product to convince even the most stubborn smokers to change their lifestyle and switch to a simpler and more intuitive device.


Reference: [1] Philip Morris International Inc. (PMI) has released its financial results for the fourth quarter and full-year of 2022.


According to a report, two million smokers in Italy have switched to using IQOS.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Canadian Media Investigation: BAT’s Nicotine Pouch ZONNIC Sparks Ongoing Controversy as Regulatory Gaps in Canada Come Under Scrutiny
Canadian Media Investigation: BAT’s Nicotine Pouch ZONNIC Sparks Ongoing Controversy as Regulatory Gaps in Canada Come Under Scrutiny
Canadian outlet Rebel News released a long-form video report examining Canada’s regulatory framework for nicotine pouches, market dynamics, and the approval process of ZONNIC, a product of BAT subsidiary Imperial Tobacco Canada. The report highlights issues involving youth access, regulatory gaps, black-market activity, retailer feedback, and company responses. This article summarizes key points based on the video.
Dec.02 by 2FIRSTS.ai
China’s E-Cigarette Exports USD 1.096 billion in November, UK and South Korea Offset U.S. Decline
China’s E-Cigarette Exports USD 1.096 billion in November, UK and South Korea Offset U.S. Decline
China’s e-cigarette exports edged lower in November 2025, totaling USD 1.096 billion, down 0.2% month-on-month, as a decline in shipments to the United States was partially offset by stronger demand from the United Kingdom, Germany and South Korea, according to data released by the General Administration of Customs of China.
Dec.22 by 2FIRSTS.ai
Complete Vape Prohibition Takes Effect Across Uzbekistan
Complete Vape Prohibition Takes Effect Across Uzbekistan
Uzbekistan has enacted a nationwide ban on the sale and circulation of e-cigarettes and related vape liquids, following the approval of a new law signed by President Shavkat Mirziyoyev. The legislation introduces criminal liability for violations, with penalties including fines of 300 to 500 basic calculation units (approximately US$10,300–17,200), corrective labor for up to three years, or imprisonment for up to five years.
Nov.28 by 2FIRSTS.ai
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai
Russian Duma Committee Moves to Embed Local Vape Prohibitions
Russian Duma Committee Moves to Embed Local Vape Prohibitions
Fedot Tumusov, First Deputy Chair of the Duma Health Committee, called vapes the “most dangerous and least controlled” nicotine product and said restricting them should be a priority. While refining a government bill, the committee proposes granting regions the power to ban vape sales. Committee Chair Sergey Leonov said the illicit e-cig market exceeds 60%, with new licensing aimed at cleaning up the sector.
Oct.30 by 2FIRSTS.ai
Belgium Plans to Ban All Vape Flavours Except Tobacco, Backed by Health Council
Belgium Plans to Ban All Vape Flavours Except Tobacco, Backed by Health Council
Belgian Health Minister Frank Vandenbroucke has announced plans to ban all e-cigarette flavours except tobacco, following new advice from the Superior Health Council (CSS). The move marks a major policy shift, as the Council now fully supports flavour restrictions to curb youth vaping.
Nov.19 by 2FIRSTS.ai